Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2019.7375
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Toxicity of Phase I Radiation Oncology Trials: Worldwide Experience

2010English

Communication About the Risks and Benefits of Phase I Pediatric Oncology Trials

Contemporary Clinical Trials
MedicinePharmacology
2015English

The Role of Age on Dose-Limiting Toxicities (DLTs) in Phase I Dose-Escalation Trials.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Dose–Response Relationship Between Exercise and Respiratory Disease Mortality

Medicine and Science in Sports and Exercise
Sports MedicinePhysical TherapySports ScienceOrthopedicsSports TherapyRehabilitation
2014English

Perceptions and Referral Trends Into Phase I Oncology Trials: Results of a Clinical Survey

Journal of Oncology
Oncology
2011English

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

Dose-Response Relationship Between Naloxone Injections and Intake of Sucrose Solution

Bulletin of the Psychonomic Society
1981English

Critical Appraisal of Clinical Trials in Oncology — Part I

Oncology in Clinical Practice
Oncology
2019English

Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy